Thing

Pharmacists made 150,000 patient interventions during anticoagulant safety audits, report finds

The results of the two national audits revealed a significant increase in patients with a yellow anticoagulant alert card, from 66.5% in 2021/2023 to 73.3% in 2023/2024.…

MHRA approves dupilumab for treatment of uncontrolled COPD

The regulator has granted marketing authorisation for a subcutaneous injection as an add-on maintenance treatment for adults with uncontrolled COPD.…

Director for RPS Scotland wins FIP Congress oral presentation prize

Laura Wilson said she hopes her presentation helped to encourage pharmacists “from across the world to consider how hospital clinical pharmacy services can be transformed to enhance patient care”.…

Statins offer cost-effective benefit for older people, study results suggest

The researchers found that lifetime use of a standard statin therapy increased quality-adjusted life years by 0.24–0.70 per person.…

Weekly insulin injection as effective as daily injections in type 1 and type 2 diabetes, research suggests

Two studies have suggested that a once-weekly injection of insulin has a similar effectiveness for blood sugar management as daily injections.…

Pharmacy organisations sign up to ‘Medicines to Gaza’ campaign

Following on from the success of the ‘Medicines to Ukraine’ model, which raised £4.5m, the Pharmacists’ Defence Association announced the new Gaza scheme at the International Pharmaceutical Federation Congress in Cape Town on 3 September 2024.…

Whole-pack dispensing to be introduced from January 2025 following legislation change

Community Pharmacy England says professional judgement should be used to assess whether dispensing 10% more or less than the quantity prescribed is appropriate.…

Call for papers: palliative and end-of-life care

The Pharmaceutical Journal would like to invite UK pharmacy professionals to let us know what they are doing in their local area to improve access to palliative and end-of-life care.…

Men taking valproate advised by MHRA to use effective contraception

The regulator advises that males and their partners should use effective contraception during, and for at least three months after, valproate treatment.…

MHRA finds no link between GLP-1 receptor agonists and suicidal behaviour

The regulator says it will continue to monitor the risk of severe psychiatric reactions and assess new data as they become available.…